Citadel Advisors
AMED

Citadel Advisors’s Amedisys AMED Stock Holding History

Citadel Advisors’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6,800
Closed -$669K – 12676
2025
Q2 		$669K Buy
6,800
+400
+6% +$37.8K ﹤0.01% 7944
2025
Q1 		$593K Sell
6,400
-5,100
-44% -$470K ﹤0.01% 8103
2024
Q4 		$1.04M Buy
11,500
+7,700
+203% +$707K ﹤0.01% 6914
2024
Q3 		$367K Sell
3,800
-600
-14% -$58.5K ﹤0.01% 8888
2024
Q2 		$404K Buy
4,400
+1,100
+33% +$102K ﹤0.01% 8496
2024
Q1 		$304K Buy
3,300
+800
+32% +$75K ﹤0.01% 9425
2023
Q4 		$238K Buy
2,500
+1,000
+67% +$93.4K ﹤0.01% 9614
2023
Q3 		$140K Sell
1,500
-900
-38% -$83.2K ﹤0.01% 10459
2023
Q2 		$219K Sell
2,400
-15,900
-87% -$1.3M ﹤0.01% 9682
2023
Q1 		$1.35M Sell
18,300
-8,100
-31% -$701K ﹤0.01% 6141
2022
Q4 		$2.21M Sell
26,400
-9,700
-27% -$875K ﹤0.01% 5294
2022
Q3 		$3.49M Sell
36,100
-11,800
-25% -$1.41M ﹤0.01% 4502
2022
Q2 		$5.04M Sell
47,900
-11,000
-19% -$1.41M ﹤0.01% 3778
2022
Q1 		$10.1M Sell
58,900
-14,100
-19% -$2.11M ﹤0.01% 2936
2021
Q4 		$11.8M Buy
73,000
+10,100
+16% +$1.62M ﹤0.01% 2784
2021
Q3 		$9.38M Buy
62,900
+48,400
+334% +$10.1M ﹤0.01% 3193
2021
Q2 		$3.55M Sell
14,500
-7,800
-35% -$2.05M ﹤0.01% 5217
2021
Q1 		$5.91M Buy
22,300
+4,600
+26% +$1.3M ﹤0.01% 3903
2020
Q4 		$5.19M Buy
17,700
+9,100
+106% +$2.33M ﹤0.01% 3611
2020
Q3 		$2.03M Sell
8,600
-3,700
-30% -$841K ﹤0.01% 4679
2020
Q2 		$2.44M Sell
12,300
-900
-7% -$168K ﹤0.01% 4210
2020
Q1 		$2.42M Buy
13,200
+200
+2% +$35.6K ﹤0.01% 3837
2019
Q4 		$2.17M Sell
13,000
-11,700
-47% -$1.74M ﹤0.01% 4280
2019
Q3 		$3.24M Buy
24,700
+9,100
+58% +$1.18M ﹤0.01% 3730
2019
Q2 		$1.89M Buy
15,600
+3,500
+29% +$415K ﹤0.01% 4596
2019
Q1 		$1.49M Sell
12,100
-13,200
-52% -$1.66M ﹤0.01% 4923
2018
Q4 		$2.96M Buy
25,300
+3,300
+15% +$389K ﹤0.01% 3533
2018
Q3 		$2.75M Buy
22,000
+11,000
+100% +$1.21M ﹤0.01% 3869
2018
Q2 		$940K Buy
11,000
+3,600
+49% +$264K ﹤0.01% 5329
2018
Q1 		$447K Sell
7,400
-5,500
-43% -$313K ﹤0.01% 6081
2017
Q4 		$680K Buy
12,900
+2,500
+24% +$132K ﹤0.01% 5203
2017
Q3 		$582K Buy
10,400
+2,500
+32% +$132K ﹤0.01% 5090
2017
Q2 		$496K Buy
7,900
+1,600
+25% +$93.2K ﹤0.01% 5121
2017
Q1 		$322K Buy
+6,300
New +$300K ﹤0.01% 5783
2016
Q4 		– Sell
-5,800
Closed -$275K – 7199
2016
Q3 		$275K Sell
5,800
-16,900
-74% -$843K ﹤0.01% 5813
2016
Q2 		$1.15M Buy
22,700
+6,300
+38% +$318K ﹤0.01% 3395
2016
Q1 		$793K Sell
16,400
-9,700
-37% -$374K ﹤0.01% 3762
2015
Q4 		$1.03M Sell
26,100
-17,500
-40% -$700K ﹤0.01% 3532
2015
Q3 		$1.66M Sell
43,600
-11,500
-21% -$485K ﹤0.01% 3183
2015
Q2 		$2.19M Buy
55,100
+24,200
+78% +$754K ﹤0.01% 2968
2015
Q1 		$828K Sell
30,900
-13,600
-31% -$384K ﹤0.01% 4184
2014
Q4 		$1.31M Buy
44,500
+17,100
+62% +$422K ﹤0.01% 3414
2014
Q3 		$553K Buy
27,400
+4,700
+21% +$90.7K ﹤0.01% 4479
2014
Q2 		$380K Buy
22,700
+13,700
+152% +$194K ﹤0.01% 4742
2014
Q1 		$134K Sell
9,000
-22,600
-72% -$348K ﹤0.01% 5899
2013
Q4 		$462K Sell
31,600
-19,300
-38% -$311K ﹤0.01% 4122
2013
Q3 		$876K Buy
50,900
+5,900
+13% +$87.5K ﹤0.01% 3242
2013
Q2 		$523K Buy
+45,000
New +$515K ﹤0.01% 3798

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Citadel Advisors's AMED Position: Q3 2025 in Review

Citadel Advisors sold out of Amedisys (AMED) in Q3 2025, closing a stake of 128,947 shares — an estimated $12.7M sold.

Citadel Advisors first reported a position in AMED in Q4 2013 and held it in 42 quarters. The position peaked at $79.3M in Q4 2024. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Citadel Advisors reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Citadel Advisors sold 128,947 Amedisys shares in Q3 2025, an estimated $12.7M.
  • Citadel Advisors first reported a position in Amedisys in Q4 2013 and held it in 42 quarters.
  • Citadel Advisors's Amedisys position peaked at $79.3M in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Citadel Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.